33.73
1.78%
-0.61
Handel nachbörslich:
33.73
Finanzdaten der Ionis Pharmaceuticals Inc-Aktie (IONS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
63.18%
119.50
|
324.50 | 144.21 | 188.41 | 130.52 |
Cost Of Revenue |
29.75%
2.151
|
3.062 | 2.191 | 2.537 | 1.343 |
Gross Profit |
63.49%
117.35
|
321.44 | 142.02 | 185.87 | 129.18 |
Operating Expenses
|
19.29%
266.86
|
330.63 | 285.28 | 276.07 | 243.33 |
Interest Income/Expense |
8.93%
4.151
|
4.558 | 4.203 | 2.291 | 1.608 |
Benefits Costs and Expenses |
20.69%
262.23
|
330.63 | 285.01 | 265.86 | 243.47 |
Costs And Expenses |
18.64%
269.01
|
330.63 | 287.47 | 278.61 | 244.67 |
Operating Income/Loss |
2,342%
-149.51
|
-6.122 | -143.26 | -90.19 | -114.15 |
Income/Loss From Continuing Operations Before Tax |
2,231%
-142.73
|
-6.122 | -140.81 | -77.45 | -112.94 |
Income Tax Expense/Benefit |
98.85%
0.075
|
6.496 | 6.602 | 7.842 | 11.38 |
Income/Loss From Continuing Operations After Tax |
1,442%
-142.80
|
-9.263 | -147.41 | -85.29 | -124.32 |
Net Income/Loss
|
1,442%
-142.80
|
-9.263 | -147.41 | -85.29 | -124.32 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
105.36K%
145.54
|
0.138 | 143.32 | 143.10 | 142.74 |
Diluted Average Shares |
105.36K%
145.54
|
0.138 | 143.32 | 143.10 | 142.74 |
Basic Earnings Per Share |
1,533%
-0.98
|
-0.06 | -1.03 | -0.60 | -0.87 |
Diluted Earnings Per Share |
1,533%
-0.98
|
-0.06 | -1.03 | -0.60 | -0.87 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):